Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant.


Journal

Journal of the American Society of Nephrology : JASN
ISSN: 1533-3450
Titre abrégé: J Am Soc Nephrol
Pays: United States
ID NLM: 9013836

Informations de publication

Date de publication:
12 2020
Historique:
received: 04 05 2020
accepted: 25 07 2020
pubmed: 11 9 2020
medline: 13 3 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Mortality risk after kidney transplantation can vary significantly during the post-transplant course. A contemporary assessment of trends in all-cause and cause-specific mortality at different periods post-transplant is required to better inform patients, clinicians, researchers, and policy makers. We included all first kidney-only transplant recipients from 1980 through 2018 from the Australia and New Zealand Dialysis and Transplant Registry. We compared adjusted death rates per 5-year intervals, using a piecewise exponential survival model, stratified by time post-transplant or time post-graft failure. Of 23,210 recipients, 4765 died with a functioning graft. Risk of death declined over successive eras, at all periods post-transplant. Reductions in early deaths were most marked; however, recipients ≥10 years post-transplant were 20% less likely to die in the current era compared with preceding eras (2015-2018 versus 2005-2009, adjusted hazard ratio, 0.80; 95% confidence interval, 0.69 to 0.90). In 2015-2018, cardiovascular disease was the most common cause of death, particularly in months 0-3 post-transplant (1.18 per 100 patient-years). Cancer deaths were rare early post-transplant, but frequent at later time points (0.93 per 100 patient-years ≥10 years post-transplant). Among 3657 patients with first graft loss, 2472 died and were not retransplanted. Death was common in the first year after graft failure, and the cause was most commonly cardiovascular (50%). Reductions in death early and late post-transplant over the past 40 years represent a major achievement. Reductions in cause-specific mortality at all time points post-transplant are also apparent. However, relatively greater reductions in cardiovascular death have increased the prominence of late cancer deaths.

Sections du résumé

BACKGROUND
Mortality risk after kidney transplantation can vary significantly during the post-transplant course. A contemporary assessment of trends in all-cause and cause-specific mortality at different periods post-transplant is required to better inform patients, clinicians, researchers, and policy makers.
METHODS
We included all first kidney-only transplant recipients from 1980 through 2018 from the Australia and New Zealand Dialysis and Transplant Registry. We compared adjusted death rates per 5-year intervals, using a piecewise exponential survival model, stratified by time post-transplant or time post-graft failure.
RESULTS
Of 23,210 recipients, 4765 died with a functioning graft. Risk of death declined over successive eras, at all periods post-transplant. Reductions in early deaths were most marked; however, recipients ≥10 years post-transplant were 20% less likely to die in the current era compared with preceding eras (2015-2018 versus 2005-2009, adjusted hazard ratio, 0.80; 95% confidence interval, 0.69 to 0.90). In 2015-2018, cardiovascular disease was the most common cause of death, particularly in months 0-3 post-transplant (1.18 per 100 patient-years). Cancer deaths were rare early post-transplant, but frequent at later time points (0.93 per 100 patient-years ≥10 years post-transplant). Among 3657 patients with first graft loss, 2472 died and were not retransplanted. Death was common in the first year after graft failure, and the cause was most commonly cardiovascular (50%).
CONCLUSIONS
Reductions in death early and late post-transplant over the past 40 years represent a major achievement. Reductions in cause-specific mortality at all time points post-transplant are also apparent. However, relatively greater reductions in cardiovascular death have increased the prominence of late cancer deaths.

Identifiants

pubmed: 32908001
pii: ASN.2020050566
doi: 10.1681/ASN.2020050566
pmc: PMC7790214
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2887-2899

Informations de copyright

Copyright © 2020 by the American Society of Nephrology.

Références

Kidney Int. 2015 Mar;87(3):575-83
pubmed: 25317931
Clin J Am Soc Nephrol. 2008 May;3(3):814-21
pubmed: 18322046
Nephrology (Carlton). 2019 Mar;24(3):322-329
pubmed: 29493847
Kidney Int. 2017 Aug;92(2):297-305
pubmed: 28709600
Am J Transplant. 2011 Mar;11(3):450-62
pubmed: 20973913
Aust N Z J Public Health. 2003;27(4):419-24
pubmed: 14705305
Am J Kidney Dis. 2015 Sep;66(3):489-98
pubmed: 25958081
Transplantation. 2017 Aug;101(8):1875-1886
pubmed: 28738403
Clin J Am Soc Nephrol. 2020 Mar 6;15(3):392-400
pubmed: 32075809
Kidney Int. 2000 Jan;57(1):307-13
pubmed: 10620213
J Am Soc Nephrol. 2019 Feb 14;:
pubmed: 30765426
Kidney Int. 2018 Nov;94(5):964-973
pubmed: 30049474
Nephrol Dial Transplant. 2001 Aug;16(8):1545-9
pubmed: 11477152
Transplantation. 2010 Apr 15;89(7):851-7
pubmed: 20048695
Nephrol Dial Transplant. 2016 May;31(5):831-41
pubmed: 26361801
Am J Transplant. 2004 Aug;4(8):1289-95
pubmed: 15268730
Clin J Am Soc Nephrol. 2018 May 7;13(5):755-762
pubmed: 29622669
Transplantation. 2017 Jul;101(7):1527-1534
pubmed: 28207630
J Am Soc Nephrol. 2019 Sep;30(9):1697-1707
pubmed: 31308074
Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1484-1492
pubmed: 31455690
Transplantation. 2018 Dec;102(12):2065-2071
pubmed: 29781954
Nephrol Dial Transplant. 2014 Sep;29(9):1778-86
pubmed: 24895440

Auteurs

Tracey Ying (T)

Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia tracey.ying@sydney.edu.au.
Kidney Node, Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.

Bree Shi (B)

Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia tracey.ying@sydney.edu.au.
Kidney Node, Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.

Patrick J Kelly (PJ)

School of Public Health, The University of Sydney, Sydney, Australia.

Helen Pilmore (H)

Renal Department, Auckland City Hospital, Auckland, New Zealand.

Philip A Clayton (PA)

Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia.
Kidney Node, Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia.
Adelaide Medical School, University of Adelaide, Adelaide, Australia.

Steven J Chadban (SJ)

Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Camperdown, Australia.
Kidney Node, Charles Perkins Centre, The University of Sydney, Sydney, Australia.
Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH